Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ticlopidine-induced thrombocytopenia.

J J Koornstra1, A Loualidi, C J de Vries

  • 1Department of Internal Medicine, MCL-Zuid, Leeuwarden, The Netherlands.

The Netherlands Journal of Medicine
|March 18, 1999
PubMed
Summary

A patient developed severe thrombocytopenia shortly after starting ticlopidine for coronary artery stenting. Discontinuing the drug led to rapid recovery, highlighting a potential drug-induced hematologic complication.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Current surveillance in the Netherlands for urothelial carcinoma in lynch syndrome.

Familial cancer·2025
Same author

Low Incidence of Advanced Neoplasia in Serrated Polyposis Syndrome After (Sub)total Colectomy: Results of a 5-Year International Prospective Cohort Study.

The American journal of gastroenterology·2019
Same author

Clinical risk factors of colorectal cancer in patients with serrated polyposis syndrome: a multicentre cohort analysis.

Gut·2015
Same author

Predictors of colorectal neoplasia after polypectomy: based on initial and consecutive findings.

The Netherlands journal of medicine·2014
Same author

Everolimus- and sirolimus-eluting stents in patients with and without ST-segment elevation myocardial infarction.

Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation·2014
Same author

Intestinal pseudo-obstruction as a complication of paragangliomas: case report and literature review.

The Netherlands journal of medicine·2014

Area of Science:

  • Cardiology
  • Hematology
  • Pharmacology

Background:

  • Ticlopidine is an antiplatelet medication used after coronary artery stenting.
  • Hematologic complications, though rare, are known adverse effects of ticlopidine therapy.

Observation:

  • A 58-year-old woman presented with profound thrombocytopenia within one week of initiating ticlopidine treatment.
  • The patient had undergone coronary artery stenting prior to ticlopidine initiation.

Findings:

  • Discontinuation of ticlopidine resulted in a rapid and complete recovery of platelet count.
  • This suggests a strong causal link between ticlopidine use and the development of thrombocytopenia in this patient.

Implications:

  • Clinicians should maintain a high index of suspicion for ticlopidine-induced thrombocytopenia, especially in the early stages of therapy.
  • Awareness of this rare but serious hematologic complication is crucial for patient safety and appropriate management.
  • Informing patients about potential risks associated with ticlopidine is essential for shared decision-making and monitoring.

Related Experiment Videos